Navigation Links
Huda Y. Zoghbi, MD, Receives $500,000 Gruber Neuroscience Prize
Date:6/15/2011

NEW YORK, June 15, 2011 /PRNewswire/ -- Huda Y. Zoghbi, MD, will receive the 2011 Neuroscience Prize of The Peter and Patricia Gruber Foundation for her pioneering work in unlocking genetic and molecular mysteries behind a number of devastating neurological disorders, including Rett syndrome, spinocerebellar ataxia type 1, and brain tumors called medulloblastomas. Her contributions have also greatly advanced our scientific understanding of autism, Parkinson's disease, and Alzheimer's disease.

Zoghbi, 56, is a professor of pediatrics, molecular and human genetics, neurology, and neuroscience at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and a Howard Hughes Medical Institute investigator. Her work has inspired many researchers in the broad field of neurological disorders, and serves as an exemplar of how complex brain disorders can be better understood through basic genetics and molecular neuroscience.

She will receive the award November 13 in Washington D.C. at the Annual Meeting of the Society for Neuroscience and will deliver a lecture titled "Rett syndrome: Linking Epigenetics and Neuronal Plasticity."

Zoghbi began her career as a clinical pediatric neurologist, and much of her research has evolved from her early experiences with patients with rare neurological disorders. Her first major research breakthrough occurred in 1993 when she co-discovered a mutation in the gene ATXN1 that is responsible for spinocerebellar ataxia type 1, a deadly neurodegenerative disorder characterized by a progressive loss of movement. Scientists have subsequently related the discovery to other brain disorders, such as Huntington's, Alzheimer's, and Parkinson's diseases.

Professor Zoghbi is perhaps best known for her lab's 1999 identification of a mutation in the gene MECP2 that causes Rett syndrome, an autism spectrum disorder that leads seemingly healthy female toddlers to avoid eye contact, cease talking, engage in obsessive behaviors (such as constant hand-wringing), and develop other devastating symptoms. Until then, scientists were not sure this disorder was genetic. Further research by Zoghbi has uncovered much more about MECP2 mutations, including the finding that doubling levels of MECP2 can cause a host of neuropsychiatric features. These discoveries opened exciting new approaches to the study of autism and other psychiatric disorders.

Zoghbi's lab also identified Math1, a gene central to the formation of hair cells in the inner ear, which may lead to more effective treatments for certain types of deafness – especially age-related deafness and vestibular problems. Zoghbi and her team have also discovered that continuous activation of Math1 can cause granule cells in mice hindbrains to grow nonstop, which may be relevant to treating a common childhood brain tumor called medulloblastoma, and open up a new pathway for therapy in cancer.

The full release with Prize citation, other media materials, and additional background information on the Gruber Prizes can be found at our online newsroom: www.gruberprizes.org/Press.php.US Media Contact:

Foundation Contact:Cassandra Oryl

Bernetia Akin+1 (202) 309-2263

+1 (340) 775-4430pr@lunchboxcity.com

media@gruberprizes.org
'/>"/>

SOURCE The Peter and Patricia Gruber Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biochemist and Geneticist Ronald W. Davis Receives $500,000 Gruber Genetics Prize for Pioneering Work in the Development of Biotechnologies that Have Significantly Advanced the Fields of Molecular Genetics and Genomics
2. Virginia Techs Kathy Lu receives Humboldt Foundation research award
3. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Receives the Virginia Bioscience Company of the Year Award
4. MicroConstants China Receives Endorsement of OECD GLP Compliance
5. Verenium Receives CLARUS Award at MDB Capitals Bright Lights Conference 2011
6. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
7. Adeonas Multiple Sclerosis Clinical Trial Receives $1,594,553 Grant
8. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
9. Cepheid Receives FDA Clearance for Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
10. Eigen Receives Two Grant Awards from U.S. Department of Health & Human Services
11. Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):